Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Perception|January 9, 2023
Levels of orientation bias differ across digital content categories: Implications for visual perceptionNicholas Duggan, Peter Gerhardstein
Physiological Reports|September 13, 2014
A translational preclinical model of interstitial pulmonary fibrosis and pulmonary hypertension: mechanistic pathways driving disease pathophysiologyElizabeth R Jarman, Valerie S Khambata, Li Yun Ye, et al.
Immunology|August 30, 2008
Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammationMatthew Thomas, Matthew J Edwards, Elzbieta Sawicka, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2014
Novel ROCK inhibitors for the treatment of pulmonary arterial hypertensionDuncan Shaw, Greg Hollingworth, Nicolas Soldermann, et al.
American Journal of Respiratory and Critical Care Medicine|June 24, 2014
Sex-dependent influence of endogenous estrogen in pulmonary hypertensionKirsty M Mair, Audrey F Wright, Nicholas Duggan, et al.
American Journal of Respiratory and Critical Care Medicine|August 27, 2011
A novel murine model of severe pulmonary arterial hypertensionLoredana Ciuclan, Olivier Bonneau, Martin Hussey, et al.
American Journal of Respiratory Cell and Molecular Biology|August 28, 2013
An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease modelElizabeth R Jarman, Valerie S Khambata, Claire Cope, et al.
The American Journal of Pathology|October 29, 2013
Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in miceLoredana Ciuclan, Kellyann Sheppard, Liqun Dong, et al.
The American Journal of Pathology|January 1, 2009
Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotalineMatthew Thomas, Cerys Docx, Alan M Holmes, et al.
American Journal of Respiratory and Critical Care Medicine|October 23, 2012
Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expressionLoredana Ciuclan, Martin J Hussey, Victoria Burton, et al.
Pageof 2